GLYCOMIMETICS INC's ticker is GLYC and the CUSIP is 38000Q102. A total of 85 filers reported holding GLYCOMIMETICS INC in Q1 2018. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $127,000 | -36.2% | 42,036 | -20.8% | 0.00% | – |
Q4 2020 | $199,000 | -6.1% | 53,046 | -23.2% | 0.00% | – |
Q3 2020 | $212,000 | -20.6% | 69,060 | -2.8% | 0.00% | – |
Q2 2020 | $267,000 | +968.0% | 71,066 | +547.5% | 0.00% | – |
Q1 2020 | $25,000 | -92.1% | 10,975 | -81.7% | 0.00% | – |
Q4 2019 | $317,000 | +359.4% | 59,964 | +274.4% | 0.00% | – |
Q3 2019 | $69,000 | -94.0% | 16,015 | -76.6% | 0.00% | -100.0% |
Q4 2017 | $1,148,000 | +6.5% | 68,386 | -11.3% | 0.00% | 0.0% |
Q3 2017 | $1,078,000 | +25.1% | 77,056 | -0.2% | 0.00% | 0.0% |
Q2 2017 | $862,000 | – | 77,229 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 3,229,856 | $45,186,000 | 5.74% |
NEA Management Company, LLC | 8,584,128 | $120,092,000 | 4.21% |
NEXTHERA CAPITAL LP | 321,286 | $4,495,000 | 1.16% |
Redmile Group, LLC | 1,214,088 | $16,985,000 | 0.84% |
EAM Investors, LLC | 371,030 | $5,191,000 | 0.69% |
Schonfeld Strategic Advisors LLC | 500,104 | $6,996,000 | 0.64% |
ELEMENT CAPITAL MANAGEMENT LLC | 29,909 | $418,000 | 0.17% |
Jafra Capital Management LP | 16,839 | $236,000 | 0.09% |
PRENTISS SMITH & CO INC | 20,000 | $280,000 | 0.08% |
Endurant Capital Management LP | 17,607 | $246,000 | 0.08% |